LLY Eli Lilly
Depreciation Integrity 53
Capex-vs-Demand Gap 45
Insider-Selling Intensity 17
Financing Opacity / Circular Leverage 25
Energy & Diminishing Returns 30
Organic End-User Demand 57
Watch
Lilly's AI investment is a pipeline-acceleration bet that competes with its own GLP-1 dominance for narrative share — AI is additive color on a one-compound growth story, not the story itself.
Last updated:
Deep Dossier in Progress

The scored backbone above is sourced from primary filings. The full investigative dossier — claim-by-claim audit, inversion analysis, primary paper trail — is being authored. This page updates as evidence lands. No claims are fabricated or inferred here; only data the engine already holds is shown.

Key Metrics (engine data)

Forward P/E (as of May/June 2026):28Verified sheet
Trailing P/E (June 2026):~39Verified sheet
Industry median forward P/E:16Verified sheet
Lilly premium above industry median:72Verified sheet